Real-time enrollment status for this hormone-receptor-positive breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:20 PM UTC
| NCT Number | NCT06756932 |
| Recruiting Status | Recruiting |
| Condition | Hormone-receptor-positive Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 120 participants |
| Active Locations | 3 sites in the US |
| Sponsor | BeOne Medicines |
| Last Updated on CT.gov | June 22, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT06756932 is currently recruiting participants. This clinical trial study for hormone-receptor-positive breast cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by BeOne Medicines. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06756932 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06756932 was last updated 3 weeks ago (June 22, 2026). HelloStudys verifies this status automatically.